Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1032

1.
2.

Persistence of protective immunity to malaria induced by DNA priming and poxvirus boosting: characterization of effector and memory CD8(+)-T-cell populations.

Sedegah M, Brice GT, Rogers WO, Doolan DL, Charoenvit Y, Jones TR, Majam VF, Belmonte A, Lu M, Belmonte M, Carucci DJ, Hoffman SL.

Infect Immun. 2002 Jul;70(7):3493-9.

3.

Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine.

Sedegah M, Jones TR, Kaur M, Hedstrom R, Hobart P, Tine JA, Hoffman SL.

Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7648-53.

4.

Immunogenicity of Ty-VLP bearing a CD8(+) T cell epitope of the CS protein of P. yoelii: enhanced memory response by boosting with recombinant vaccinia virus.

Oliveira-Ferreira J, Miyahira Y, Layton GT, Savage N, Esteban M, Rodriguez D, Rodriguez JR, Nussenzweig RS, Zavala F.

Vaccine. 2000 Mar 6;18(17):1863-9. Erratum in: Vaccine 2000 Jun 15;18(25):2923. Myahira Y [corrected to Miyahira Y].

PMID:
10699335
5.

Improving protective immunity induced by DNA-based immunization: priming with antigen and GM-CSF-encoding plasmid DNA and boosting with antigen-expressing recombinant poxvirus.

Sedegah M, Weiss W, Sacci JB Jr, Charoenvit Y, Hedstrom R, Gowda K, Majam VF, Tine J, Kumar S, Hobart P, Hoffman SL.

J Immunol. 2000 Jun 1;164(11):5905-12.

6.

Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes.

Trimnell A, Takagi A, Gupta M, Richie TL, Kappe SH, Wang R.

J Immunol. 2009 Nov 1;183(9):5870-8. doi: 10.4049/jimmunol.0900302. Epub 2009 Oct 7.

7.

Influenza and vaccinia viruses expressing malaria CD8+ T and B cell epitopes. Comparison of their immunogenicity and capacity to induce protective immunity.

Rodrigues M, Li S, Murata K, Rodriguez D, Rodriguez JR, Bacik I, Bennink JR, Yewdell JW, Garcia-Sastre A, Nussenzweig RS, et al.

J Immunol. 1994 Nov 15;153(10):4636-48.

PMID:
7525709
8.

Protective efficacy against malaria of a combination sporozoite and erythrocytic stage vaccine.

Wang R, Charoenvit Y, Daly TM, Long CA, Corradin G, Hoffman SL.

Immunol Lett. 1996 Nov;53(2-3):83-93.

PMID:
9024983
9.

Partial protection against malaria by immunization with Leishmania enriettii expressing the Plasmodium yoelii circumsporozoite protein.

Wang HH, Rogers WO, Kang YH, Sedegah M, Hoffman SL.

Mol Biochem Parasitol. 1995 Feb;69(2):139-48.

PMID:
7770079
11.

Recombinant pseudorabies virus carrying a plasmodium gene: herpesvirus as a new live viral vector for inducing T- and B-cell immunity.

Sedegah M, Chiang CH, Weiss WR, Mellouk S, Cochran MD, Houghten RA, Beaudoin RL, Smith D, Hoffman SL.

Vaccine. 1992;10(9):578-84.

PMID:
1323900
12.
14.
15.

Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.

Tarun AS, Dumpit RF, Camargo N, Labaied M, Liu P, Takagi A, Wang R, Kappe SH.

J Infect Dis. 2007 Aug 15;196(4):608-16. Epub 2007 Jul 9.

PMID:
17624848
16.
17.

Attenuated vaccinia virus-circumsporozoite protein recombinants confer protection against rodent malaria.

Lanar DE, Tine JA, de Taisne C, Seguin MC, Cox WI, Winslow JP, Ware LA, Kauffman EB, Gordon D, Ballou WR, Paoletti E, Sadoff JC.

Infect Immun. 1996 May;64(5):1666-71.

18.

Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii.

Cong H, Gu QM, Jiang Y, He SY, Zhou HY, Yang TT, Li Y, Zhao QL.

Parasite Immunol. 2005 Jan-Feb;27(1-2):29-35.

19.

Immunological responses of neonates and infants to DNA vaccines.

Sedegah M, Hoffman SL.

Methods Mol Med. 2006;127:239-51. Review.

PMID:
16988458
20.

Supplemental Content

Support Center